Guardian Pharmacy Services, Inc. (GRDN) Financial Statements
Guardian Pharmacy Services, Inc. (GRDN) reported trailing twelve-month revenue of $1.5B (up 10.3% year on year) and net income of $65.9M as of 2026-06-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: $75.3M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
GRDNGuardian Pharmacy Services, Inc.Follow GRDN — free
—
Price chart with a free account
- Market cap
- 2.5B
- P/E TTM
- 38.7
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 17 Nov, in 24 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.
| Line | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|
| Revenue | 1.23 | 1.45 | 1.46 | |
| Gross profit | 0.24 | 0.29 | 0.32 | |
| Operating income | -0.06 | 0.07 | 0.09 | |
| Pre-tax income | -0.07 | 0.07 | 0.10 | |
| Income tax | 0.00 | 0.02 | 0.03 | |
| Net income | -0.11 | 0.05 | 0.07 | |
| Diluted EPS ($) | -1.77 | 0.78 | 1.02 | |
| Diluted shares (bn) | 0.062 | 0.063 | — |
USD billions · SEC XBRL
Guardian Pharmacy Services, Inc. — questions
- What is Guardian Pharmacy Services, Inc.'s revenue?
- $1.5B over the twelve months to 2026-06-30, up 10.3% year on year, from its 10-Q and 10-K filings.
- What is Guardian Pharmacy Services, Inc.'s net income?
- $65.9M over the twelve months to 2026-06-30.
- What is Guardian Pharmacy Services, Inc.'s free cash flow?
- $75.3M over the twelve months to 2026-06-30.
- What are Guardian Pharmacy Services, Inc.'s diluted earnings per share?
- $1.02 over the twelve months to 2026-06-30.
Every figure on this page comes from Guardian Pharmacy Services, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.